Sale of 7.7 g of Radium-226 for medical applications

Published

20 July 2026

Procedure

neg-w-call

Lots

1

Notice number

00500469-2026

Reference

a2c8b963-668e-4f26-8454-11db7332e942

Official source

Official source

CPV codes

• 09343000Materiales radiactivos

Description

The European Commission, Joint Research Centre (JRC) in Karlsruhe (Germany) plans to sell approximately 7.7 grams of Radium-226 (Ra-226), a valuable resource from its our strategic inventory utilised for cutting-edge research and development in nuclear medical applications. This includes applications in the production of Actinium-225 (Ac-225) for the use of targeted alpha therapy. Following a surge of demand for Ac-225, Ra-226 material serves as a crucial source material for producing it as well as other valuable medical radioisotopes, such as Lead-212 (Pb-212). With a growing demand and limited supply for Ra-226, the JRC Karlsruhe wants to contribute to the medical isotope supply chain. The expertise along with the state-of-the-art assets at JRC Karlsruhe, equips it to contribute effectively to this critical field. This sale is meant to bolster the availability of Ra-226 for medical applications and further the advancement of nuclear medicine.

Frequently asked questions

Who is the buyer of this tender?

The contracting authority is Europäische Kommission, Gemeinsame Forschungsstelle (JRC) (European Union).